Controversy: Pfizer CEO sold shares for 4.73 million euros
Last Monday, when the shares of the pharmaceutical company
Pfizer
surpassed the threshold of $ 41.94 in full euphoria over its advances in the vaccine against Covid-19, its chief executive officer (CEO),
Albert Bourla
, got rid of a total of 132,508 titles of the company worth 5,557 million dollars (about 4,700 million euros).
The news was known on Wednesday, once the market had assimilated the health news, and with it arose the controversy about legality,
To continue reading, go Premium
Are you already Premium?
Log in
Monthly
€ 1
first month
and then € 7.99
I want it
Annual
Save 3 months
€ 69
Free 1 year of Standard Legálitas (valued at € 240)
I want it
Discover what is Premium
Cancel whenever you want
Check the terms and conditions of the service
According to the criteria of The Trust Project
Know more